Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb

Neurokinin A and B are putative inflammatory mediators. We assessed their ability to alter prenodal lymphatic resistance. Intralymphatic neurokinin A (3.0 × 10−6, 3.0 × 10−5 and 3.0 × 10−4 mol l−1) significantly constricted lymphatics at the two highest doses. Preliminary experiments suggested that...

Full description

Saved in:
Bibliographic Details
Main Author: David E. Dobbins
Format: Article
Language:English
Published: Wiley 1992-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/S096293519200036X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524541625466880
author David E. Dobbins
author_facet David E. Dobbins
author_sort David E. Dobbins
collection DOAJ
description Neurokinin A and B are putative inflammatory mediators. We assessed their ability to alter prenodal lymphatic resistance. Intralymphatic neurokinin A (3.0 × 10−6, 3.0 × 10−5 and 3.0 × 10−4 mol l−1) significantly constricted lymphatics at the two highest doses. Preliminary experiments suggested that neurokinin B might dilate lymphatics. To test this, lymphatic pressure was increased by norepinephrine (3.1 × 10−6 mol l−1). Neurokinin B (2.7 × 10−4 mol l−1) was then infused intralymphatically during norepinephrine infusion. Norepinephrine increased perfusion pressure from 5.6 ± 0.6 mmHg to 12.1 ± 1.4 mmHg. Subsequent infusion of neurokinin B significantly decreased lymphatic perfusion pressure from 11.9 ± 1.3 mmHg to 9.9 ± 1.1 mmHg. These data indicate that neurokinin A and B can alter lymphatic resistance and are consistent with the hypothesis that lymph vessel function may be subject to modulation by neurokinins.
format Article
id doaj-art-59d7c2092c574e1bb181edfaab84f45b
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 1992-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-59d7c2092c574e1bb181edfaab84f45b2025-02-03T05:52:53ZengWileyMediators of Inflammation0962-93511466-18611992-01-011424124610.1155/S096293519200036XNeuropeptide modulation of lymphatic smooth muscle tone in the canine forelimbDavid E. Dobbins0Department of Physiology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USANeurokinin A and B are putative inflammatory mediators. We assessed their ability to alter prenodal lymphatic resistance. Intralymphatic neurokinin A (3.0 × 10−6, 3.0 × 10−5 and 3.0 × 10−4 mol l−1) significantly constricted lymphatics at the two highest doses. Preliminary experiments suggested that neurokinin B might dilate lymphatics. To test this, lymphatic pressure was increased by norepinephrine (3.1 × 10−6 mol l−1). Neurokinin B (2.7 × 10−4 mol l−1) was then infused intralymphatically during norepinephrine infusion. Norepinephrine increased perfusion pressure from 5.6 ± 0.6 mmHg to 12.1 ± 1.4 mmHg. Subsequent infusion of neurokinin B significantly decreased lymphatic perfusion pressure from 11.9 ± 1.3 mmHg to 9.9 ± 1.1 mmHg. These data indicate that neurokinin A and B can alter lymphatic resistance and are consistent with the hypothesis that lymph vessel function may be subject to modulation by neurokinins.http://dx.doi.org/10.1155/S096293519200036X
spellingShingle David E. Dobbins
Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
Mediators of Inflammation
title Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
title_full Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
title_fullStr Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
title_full_unstemmed Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
title_short Neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
title_sort neuropeptide modulation of lymphatic smooth muscle tone in the canine forelimb
url http://dx.doi.org/10.1155/S096293519200036X
work_keys_str_mv AT davidedobbins neuropeptidemodulationoflymphaticsmoothmuscletoneinthecanineforelimb